Chad Salisbury

Technical Operations, Quality and Strategy

Role
Global Head, Corporate Partnerships at Biogen
Location
Raleigh-Durham-Chapel Hill, NC, US
LinkedIn followers
500 followers

About Chad Salisbury

An innovative Technical Operations and Quality leader in the pharmaceutical/biotech industry with over 20 years of experience encompassing cell and gene therapies, vaccines, sterile injectables, small molecules, adjuvants and medical devices. Has successfully executed multiple process scale-ups/technical transfers from process development into a GMP facility in small molecule manufacturing (Eli Lilly), vaccines (Novartis) and gene therapies (Affinia). Has also delivered $1.8B USD of greenfield cGMP manufacturing facilities from design through FDA/EMA licensure. Has advised leading advanced therapies companies in developing their technical operations and quality strategies to support clinical development and commercialization of innovative therapies.

Experience

  1. Global Head, Corporate Partnerships

    Biogen

    Aug 2024 — Present · Raleigh-Durham-Chapel Hill, NC, US

Education

  • Duke University

    Masters, Environmental Management

    1994 — 1996

  • Purdue University Daniels School of Business

    Master of Business Administration - MBA

    2002 — 2004

  • Alfred University

    Bachelor, Mathematics, Environmental Science

    1990 — 1994

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Chad Salisbury — Global Head, Corporate Partnerships at Biogen in Raleigh-Durham-Chapel Hill, NC, US | Unifers